Stem-cell therapy opens new avenue of research against Huntington's disease

Paying close attention to how a canary learns a new song has helped scientists open a new avenue of research against Huntington's disease - a fatal disorder for which there is currently no cure or even a treatment to slow the disease.
In a paper published Sept. 20 in the Journal of Clinical Investigation, scientists at the University of Rochester Medical Center have shown how stem-cell therapy might someday be used to treat the disease. The team used gene therapy to guide the development of endogenous stem cells in the brains of mice affected by a form of Huntington's. The mice that were treated lived significantly longer, were healthier, and had many more new, viable brain cells than their counterparts that did not receive the treatment.
 
Stem-cell therapy opens new avenue of research against Huntington's disease
 (news-medical.net)